Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KI-1115
- Development stage
- Unknown
- Lead developer
- Kuhnil Pharmaceutical
- Modality
- Small Molecules
01
Overview
**KI-1115** is a Kuhnil Pharma development code for an approved pharmaceutical product listed by the company for **iron poisoning**. Public pipeline and drug-database records characterize it as a small-molecule **iron-chelating agent** intended to bind excess iron and support its removal from the body. The exact active chemical entity, formulation, route of administration, and marketed brand name have not been publicly identified in the sources reviewed.
- Other names
- KI 1115KI1115KI-1115
Beyond the preview
Go deeper on KI-1115.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KI-1115.